Pyxis Oncology (PYXS) Prepaid Assets (2020 - 2025)

Pyxis Oncology (PYXS) has 6 years of Prepaid Assets data on file, last reported at $3.8 million in Q4 2025.

• Prepaid Assets for Q4 2025 came in at $3.8 million, down 6.47% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.8 million (down 6.47% YoY), and the FY2025 annual result was $3.8 million, down 6.47% from the prior year.
• Prepaid Assets fell to $3.8 million in Q4 2025 per PYXS's latest filing, from $5.3 million in the prior quarter.
• Over five years, Prepaid Assets peaked at $6.5 million in Q2 2025 and troughed at $859000.0 in Q3 2021.
• A 5-year average of $4.0 million and a median of $3.9 million in 2024 frame the typical range for Prepaid Assets.
• The sharpest annual moves came in 2021 and 2024: Prepaid Assets surged 10621.74% in 2021, then sank 44.62% in 2024.
• A 5-year view of Prepaid Assets shows it stood at $2.5 million in 2021, then jumped by 137.1% to $5.8 million in 2022, then plunged by 34.43% to $3.8 million in 2023, then increased by 5.29% to $4.0 million in 2024, then decreased by 6.47% to $3.8 million in 2025.
• Business Quant data shows PYXS's Prepaid Assets at $3.8 million in Q4 2025, $5.3 million in Q3 2025, and $6.5 million in Q2 2025.